Published in J Clin Microbiol on January 01, 1997
Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol (2000) 1.92
Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group. J Clin Microbiol (1997) 1.85
Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems. J Clin Microbiol (1997) 1.60
Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia. Ann Saudi Med (2011) 1.56
European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol (2005) 1.53
VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol (2002) 1.45
Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol (2005) 1.43
Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens. Clin Diagn Lab Immunol (2000) 1.39
Cardiac involvement with parasitic infections. Clin Microbiol Rev (2010) 1.32
Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands. Clin Diagn Lab Immunol (2001) 1.22
Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis (2007) 1.18
Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products. J Clin Microbiol (2006) 1.17
LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol (2008) 1.15
Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen. J Clin Microbiol (2000) 1.14
Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res (2008) 1.10
Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol (1998) 1.10
Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol (2000) 1.06
Seroepidemiology of infection with Toxoplasma gondii in migrant agricultural workers living in poverty in Durango, Mexico. Parasit Vectors (2013) 1.03
Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy. J Clin Microbiol (2004) 1.02
Detection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women. J Clin Microbiol (2000) 1.00
Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey. Mol Cell Proteomics (2011) 0.98
Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies. Clin Vaccine Immunol (2013) 0.98
Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies. Clin Vaccine Immunol (2009) 0.96
Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women. Clin Vaccine Immunol (2011) 0.95
Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin Diagn Lab Immunol (2004) 0.95
Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methods. J Clin Microbiol (2011) 0.93
Seroprevalence of Toxoplasma gondii infection and associated risk factors in Huicholes in Mexico. Parasit Vectors (2014) 0.91
Toxoplasma infection in pregnant women: a current status in Songklanagarind hospital, southern Thailand. Parasit Vectors (2014) 0.90
Detection of anti-Toxoplasma immunoglobulin M in pregnant women. J Clin Microbiol (1997) 0.90
Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States. J Clin Microbiol (2015) 0.90
Fast dipstick dye immunoassay for detection of immunoglobulin G (IgG) and IgM antibodies of human toxoplasmosis. Clin Diagn Lab Immunol (2005) 0.88
Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus. PLoS One (2011) 0.88
Arboprotozoae. Transfus Med Hemother (2009) 0.86
Toxoplasmosis and pregnancy. Can Fam Physician (2014) 0.84
Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy. Clin Vaccine Immunol (2010) 0.84
High Seroprevalence of Toxoplasma Gondii Infection in Female Sex Workers: A Case-Control Study. Eur J Microbiol Immunol (Bp) (2015) 0.82
Development and clinical evaluation of a rapid serodiagnostic test for toxoplasmosis of cats using recombinant SAG1 antigen. Korean J Parasitol (2011) 0.81
The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis. J Clin Microbiol (2007) 0.81
Simple and efficient method for measuring anti-toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase. J Clin Microbiol (2001) 0.81
Toxoplasma gondii exposure in patients suffering from mental and behavioral disorders due to psychoactive substance use. BMC Infect Dis (2015) 0.78
rROP2(186-533): a novel peptide antigen for detection of IgM antibodies against Toxoplasma gondii. Foodborne Pathog Dis (2011) 0.78
Survey of obstetrician-gynecologists in the United States about toxoplasmosis: 2012 update. Arch Gynecol Obstet (2014) 0.77
Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. J Clin Microbiol (2008) 0.77
Association Between Toxoplasma gondii Exposure and Heart Disease: A Case-Control Study. J Clin Med Res (2016) 0.77
Design of Indigenous ELISA Using Tachyzoites from the RH Strain of Toxoplasma gondii and Comparison with Commercial Kits in Ahvaz, Southwest of Iran, 2015. Jundishapur J Microbiol (2016) 0.77
Seroepidemiology of Toxoplasmosis among People Having Close Contact with Animals. Front Immunol (2015) 0.76
Expression and Purification of Recombinant ROP1 of Toxoplasma gondii in Bacteria. Avicenna J Med Biotechnol (2013) 0.75
The necessity of confirmatory testing in serodiagnosis of toxoplasmosis in iran. Iran J Parasitol (2013) 0.75
Twenty-six circulating antigens and two novel diagnostic candidate molecules identified in the serum of canines with experimental acute toxoplasmosis. Parasit Vectors (2016) 0.75
Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis. J Clin Microbiol (2016) 0.75
A community-based survey of Toxoplasma gondii infection among pregnant women in rural areas of Taiz governorate, Yemen: the risk of waterborne transmission. Infect Dis Poverty (2017) 0.75
Cytomegalovirus, Toxoplasma gondii and Rubella Vertical Transmission Rates According to Mid-trimester Amniocentesis: A Retrospective Study. Int J Prev Med (2015) 0.75
Multicenter evaluation of the Elecsys Toxo IgG and IgM tests for the diagnosis of infection with Toxoplasma gondii. Eur J Microbiol Immunol (Bp) (2015) 0.75
Lack of association between Toxoplasma gondii exposure and depression in pregnant women: a case-control study. BMC Infect Dis (2017) 0.75
Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell's palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy. Eur Arch Otorhinolaryngol (2011) 0.75
Seroprevalence and correlates of Toxoplasma gondii infection in Yoremes (Mayos) in Mexico: a cross-sectional study. BMJ Open (2016) 0.75
Influenza M1 Virus-Like Particles Consisting of Toxoplasma gondii Rhoptry Protein 4. Korean J Parasitol (2017) 0.75
Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science (1948) 19.46
An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis. J Infect Dis (1980) 5.57
Statistical methods in microbiology. Clin Microbiol Rev (1990) 4.60
Toxoplasmosis in pregnancy. Clin Infect Dis (1994) 3.91
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis (1990) 2.49
Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis (1993) 2.45
Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol (1990) 2.19
Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J Clin Microbiol (1996) 1.78
Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis (1995) 1.69
Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol (1993) 1.68
High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Case report. Gynecol Obstet Invest (1991) 1.62
Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol (1987) 1.55
Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J Clin Microbiol (1989) 1.37
Five commercial enzyme linked immunosorbent assay kits for toxoplasma specific IgM antibody. J Clin Pathol (1989) 1.31
[Evaluation of the Vidas system for the serological diagnosis of toxoplasmosis]. Ann Biol Clin (Paris) (1993) 1.29
Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii. J Clin Pathol (1989) 1.26
Comparison of relative uses of commercial assays for Toxoplasma gondii IgM antibodies. J Clin Pathol (1992) 1.25
Performance of European laboratories testing serum samples for Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (1996) 1.20
Multicenter evaluation of a new commercial assay for detection of immunoglobulin M antibodies to Toxoplasma gondii. Multicenter Study Group. Eur J Clin Microbiol Infect Dis (1995) 1.15
Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer. J Clin Microbiol (1989) 1.12
The Vitek immunodiagnostic assay for detection of immunoglobulin M toxoplasma antibodies. Clin Diagn Lab Immunol (1994) 1.08
Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii. J Clin Microbiol (1996) 0.97
Automated microparticle enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii. J Clin Pathol (1991) 0.90
Evaluation of three commercial enzyme immunoassays for toxoplasma and cytomegalovirus antibodies. Am J Clin Pathol (1991) 0.89
[A multicenter study of IgG and IgM toxo-test enzymun]. Ann Biol Clin (Paris) (1989) 0.85
Comparative study of three immunoassays for detection of immunoglobulin M antibodies against Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (1988) 0.84
Enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii based on enhanced chemiluminescence. J Clin Pathol (1995) 0.82
Measurement of Toxoplasma IgM by a microparticle capture enzyme immuno-assay. J Med Microbiol (1993) 0.82
The generation of a ColE1-Apr cloning vehicle which allows detection of inserted DNA. Mol Gen Genet (1975) 8.80
Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science (1988) 7.96
Toxoplasmic encephalitis in AIDS. Clin Infect Dis (1992) 7.64
An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis. J Infect Dis (1980) 5.57
Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med (1980) 5.23
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med (1974) 4.39
Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet (1997) 4.36
AIDS commentary. Toxoplasmic encephalitis. J Infect Dis (1988) 4.14
Toxoplasmosis in pregnancy. Clin Infect Dis (1994) 3.91
Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol (1980) 3.81
In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes. Infect Immun (1971) 3.81
Analysis of sequences transposed by complementation of two classes of transposition-deficient mutants of Tn3. J Bacteriol (1978) 3.69
Control of carcinogenesis: a possible role for the activated macrophage. Science (1972) 3.69
Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science (1968) 3.65
Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol (1983) 3.53
Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA (1984) 3.48
Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol (1969) 3.29
Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics (1980) 3.21
Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol (1989) 3.20
A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun (1972) 3.12
IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J Lab Clin Med (1968) 3.07
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med (1996) 2.97
Toxoplasmosis in the compromised host. Ann Intern Med (1976) 2.96
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet (1997) 2.86
Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products. J Immunol (1976) 2.79
Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol (1988) 2.77
Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis (2001) 2.74
External fibronectin of cultured human fibroblasts is predominantly a matrix protein. J Cell Biol (1978) 2.70
Phagocytic and bacterial properties of normal human monocytes. J Clin Invest (1974) 2.65
Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol (1981) 2.61
Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis (1971) 2.58
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother (1991) 2.56
Toxoplasmosis: the time has come. N Engl J Med (1988) 2.54
Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi. J Immunol (1986) 2.53
IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis (1990) 2.49
Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis Child (1989) 2.49
Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun (1994) 2.48
The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J Immunol (1990) 2.47
The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii. J Immunol (1972) 2.46
Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis (1993) 2.45
Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol (1972) 2.44
Detection and characterization of membrane antigens of Toxoplasma gondii. J Immunol (1980) 2.43
Infectious complications after cardiac transplantation in man. Ann Intern Med (1971) 2.37
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Ann Intern Med (1999) 2.36
IgM antibodies in acute toxoplasmosis. I. Diagnostic significance in congenital cases and a method for their rapid demonstration. Pediatrics (1968) 2.36
Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J Infect Dis (1971) 2.34
Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res (1991) 2.30
Effect of murine interferon gamma on murine toxoplasmosis. J Infect Dis (1984) 2.27
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
Antigenemia in recently acquired acute toxoplasmosis. J Infect Dis (1980) 2.20
Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol (1990) 2.19
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Polypeptides expressed in Escherichia coli K-12 minicells by transposition elements Tn1 and Tn3. J Bacteriol (1979) 2.17
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob Agents Chemother (1988) 2.16
Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med (1973) 2.15
Effect of clindamycin on acute and chronic toxoplasmosis in mice. Antimicrob Agents Chemother (1974) 2.14
Gamma-M-fluorescent treponemal antibody in the diagnosis of congenital syphilis. N Engl J Med (1969) 2.10
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis (2001) 2.09
Toxoplasmosis in the adult--an overview. N Engl J Med (1978) 2.06
Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis (1996) 2.04
IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. J Pediatr (1981) 2.04
Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis (1991) 2.04
Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis (1981) 2.03
Method for avoiding false-positive results occurring in immunoglobulin M enzyme-linked immunosorbent assays due to presence of both rheumatoid factor and antinuclear antibodies. J Clin Microbiol (1981) 2.03
Tropical fish aquariums. A source of Mycobacterium marinum infections resembling sporotrichosis. JAMA (1970) 2.00
In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii. J Immunol (1985) 2.00
Serologic diagnosis of acute lymphadenopathic toxoplasmosis. J Infect Dis (1980) 1.99
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol (1990) 1.95
Dissociation of effector functions in populations of activated macrophages. Nature (1977) 1.95
Analysis of Toxoplasma gondii antigens recognized by human sera obtained before and after acute infection. J Infect Dis (1986) 1.93
The RNA of toxoplasma gondii. Proc Soc Exp Biol Med (1970) 1.93
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol (1999) 1.92
Synthetic polyanions protect mice against intracellular bacterial infection. Nature (1970) 1.92
Genetic control of murine resistance to Toxoplasma gondii. Infect Immun (1978) 1.91
Immunity and intracellular infection: resistance to bacteria in mice infected with a protozoan. Science (1968) 1.88
A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen. J Immunol Methods (1979) 1.87
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86
Opportunistic invasive fungal infections in patients with leukaemia lymphoma. Clin Haematol (1976) 1.86
Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group. J Clin Microbiol (1997) 1.85
False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies. Appl Microbiol (1971) 1.85
Strain-dependent differences in murine susceptibility to toxoplasma. Infect Immun (1976) 1.85
Pulmonary infection in the compromised host: part I. Am Rev Respir Dis (1976) 1.82
The role of thymus-derived lymphocytes in the in vitro activation of macrophages to kill Listeria monocytogenes. J Immunol (1973) 1.82
The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg (1979) 1.82
Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections. Hum Pathol (1981) 1.81
Computer simulation model of an x-ray department. Br Med J (1972) 1.80
Uukuniemi virus maturation: accumulation of virus particles and viral antigens in the Golgi complex. Mol Cell Biol (1982) 1.80
Toxoplasmosis in the non-AIDS immunocompromised host. Curr Clin Top Infect Dis (1993) 1.80
Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet (1983) 1.80
Biology of Toxoplasma gondii. AIDS (1993) 1.79
Comparison of methods for quantitating antigen-specific immunoglobulin M antibody with a reverse enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.79
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem (1996) 1.79
Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J Clin Microbiol (1996) 1.78